Levetiracetam Accord

Levetiracetam, the active ingredient in Levetiracetam Accord, is an anticonvulsant presented as an intravenous solution for intravenous use. It is indicated for the treatment of partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other global markets. The company adheres to stringent quality standards and provides regulatory support for import and clinical use throughout.

Levetiracetam is an anticonvulsant used to control seizure activity in epilepsy.

Partial seizures: reduces frequency of focal onset seizures Generalized tonic‑clonic seizures: helps prevent convulsive episodes Myoclonic seizures: decreases myoclonic jerks

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness - Somnolence: increased sleepiness or fatigue - Headache: mild to moderate cranial pain - Irritability: mood changes or agitation

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis - Psychiatric disturbances: depression, suicidal thoughts, or aggressive behavior - Blood disorders: thrombocytopenia or neutropenia

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

Renal function: adjust dosing in patients with impaired renal clearance. Pregnancy: potential risks are unknown; weigh benefits against possible fetal exposure. Concomitant CNS depressants: monitor for additive sedation. Mood changes: observe for new or worsening psychiatric symptoms. Discontinuation: taper gradually to avoid seizure recurrence. Store at room temperature: keep in original container, protect from light and moisture.

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine, phenytoin, phenobarbital: may lower levetiracetam plasma concentrations. - Live vaccines: reduced vaccine efficacy may occur.

Moderate Interactions (Monitor Closely): - Alcohol: may increase central nervous system depression. - Other antiepileptic drugs: may require dose adjustments. - Renally toxic agents: monitor renal function closely when co‑administered.